Dr. Janjigian Discusses Afatinib and Cetuximab for Patients With EGFR-Mutant Lung Cancer

onclivetv has 407 videos Subscribe Here

Description: Dr. Janjigian discusses results of an early-phase study looking at afatinib and cetuximab for patients with EGFR-mutant lung cancer.
Yelena Y. Janjigian, MD, assistant attending physician, Memorial Sloan Kettering Cancer Center
More on lung cancer:
Shared By : onclivetv
Posted on : 02/23/15
Added : 4 years ago